Actively Recruiting

All Genders
ID06680583

Utilizing Physiological Parameters and Derived Indices to Predict Prognosis in Cirrhotic Patients with Gastrointestinal Bleeding

Led by St. Martin De Porress Hospital · Updated on 2026-03-17

150

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate whether physiological indicators like the quick Sequential Organ Failure Assessment, Shock Index, and related measures such as the Modified Shock Index, Age Shock Index, and Respiratory Adjusted Shock Index can accurately predict the outlook for patients with liver cirrhosis who experience gastrointestinal bleeding. Cirrhosis is a common chronic liver disease, and gastrointestinal bleeding is a serious complication with an uncertain prognosis. Developing reliable tools to assess risk can help improve emergency and critical care management for these patients. The study will observe and analyze the use of these physiological parameters in cirrhosis patients with gastrointestinal bleeding to understand their value in predicting patient outcomes. No specific treatment is given as this is an observational study focusing on assessing these indicators. Data will be collected throughout the study, which is expected to last an average of six months from the start date. Participants will be monitored using measures such as heart rate, blood pressure, and respiratory rate to calculate the Shock Index and its derivatives. Researchers will use these indicators to predict prognosis and assist in rapid treatment decisions. Study data will be gathered continuously until the study's completion, helping to improve medical care efficiency for critically ill cirrhosis patients with gastrointestinal bleeding.

CONDITIONS

Brief Title

Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of cirrhosis with gastrointestinal bleeding
Not Eligible

You will not qualify if you...

  • Incomplete medical records
  • Recent trauma injury

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 6 months

Participants with cirrhosis and gastrointestinal bleeding are observed to assess physiological parameters such as shock index and related indicators to predict prognosis.

Regular assessments during hospital stay and follow-up visits as determined by clinical care

Trial Site Locations

Total: 1 location

1

St. Martin De Porres Hospital

Tainan, Taiwan, 60069

Actively Recruiting

Loading map...

Research Team

C

Chia-Hsi Chen, Physician

C

Chung-Jing Wang, professor

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in...

Liver Cirrhosis

Actively Recruiting

9 locations

PROMISE Trial: A PROspective Randomised Double-blind Paralle...

Liver Cirrhosis

Actively Recruiting

23 locations

Development of a Breath Test Using Volatile Organic Markers ...

Liver Cirrhosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here